SCHEMBL12847759

SCHEMBL12847759

CCS[C@@H]1OC(COC(=O)c2ccccc2)[C@@H](O)C(OC(=O)c2ccccc2)C1OC(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS9 O00182 5/20 0.55
▸ LGALS1 P09382 5/20 0.55
▸ LGALS3 P17931 5/20 0.55
▸ LGALS7; LGALS7B P47929 4/20 0.55
▸ POLB P06746 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LGALS8 O00214 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ GAPDH P04406 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ PTPN1 P18031 3/20 0.41
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12848097 1.00 LGALS9 (0.55) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL1463130 0.93 LGALS9 (0.52) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL8346842 0.91 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL17193904 0.91 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL1521246 0.91 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL1521440 0.91 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL16917900 0.91 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL16917918 0.91 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL7251664 0.91 USP2 (0.49) LGALS9LGALS1LGALS3LGALS7; LGALS7BPOLB
SCHEMBL17050854 0.88 LGALS3 (0.70) LGALS9LGALS1LGALS3LGALS7; LGALS7BLGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110054156-A1 SYNTHESIS OF TIMOSAPONIN BII INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY SCIENCES, PLA (CN) 2011-03-03 — — US disclosed
WO-2009132478-A1 SYNTHESIS OF TIMOSAPONIN BII PHYTOPHARM PLC (GB) 2009-11-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054156-A1 SYNTHESIS OF TIMOSAPONIN BII GALE, GNE, BSG LGALS9 1461/4885LGALS1 1157/4885LGALS3 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback